You have 9 free searches left this month | for more free features.

Peripheral Stem Cells

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

Recruiting
  • Granuloma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Chronic Granulomatous Disease Transplant Trial run by the NIAID (drug, radiation, biological)

    Active, not recruiting
    • Chronic Granulomatous Disease Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 21, 2023

    Hematologic Diseases, Bone Marrow Transplantation, Hematopoietic Stem Cell Transplantation Trial in Paris (NewSpringForMe

    Recruiting
    • Hematologic Diseases
    • +2 more
    • NewSpringForMe digital solution
    • Paris, France
      Service Hématologie Greffe Trèfle 3, Hôpital Saint-Louis, AP-HP
    Nov 22, 2023

    Diabetic Peripheral Neuropathy Type 2 Trial in Wuhan (HUC-MSCs, Lipoic Acid)

    Recruiting
    • Diabetic Peripheral Neuropathy Type 2
    • HUC-MSCs
    • Lipoic Acid
    • Wuhan, Hubei, China
      The Central Hospital of Wuhan
    Aug 16, 2022

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

      Completed
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +14 more
      • Aldesleukin
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jul 31, 2022

      Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

      Completed
      • Leukemia
      • +2 more
      • CliniMACS Fractionation system (Arm A)
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 12, 2022

      Adenosine Deaminase Severe Combined Immune Deficiency Trial (A cryopreserved formulation of autologous mPB CD34+ hematopoietic

      Not yet recruiting
      • Adenosine Deaminase Severe Combined Immune Deficiency
      • A cryopreserved formulation of autologous mPB CD34+ hematopoietic stem and progenitor cells transduced ex vivo with the EFS-ADA lentiviral vector encoding the human ADA enzyme
      • (no location specified)
      Jun 20, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Dec 8, 2022

      Hepatitis B Trial in Changsha (Peripheral iv)

      Recruiting
      • Hepatitis B
      • Peripheral iv
      • Changsha, Hunan, China
        Xiangya Hospital Central South University
      Jul 20, 2022

      Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes Trial in Philadelphia (Transplant of stem cells with

      Recruiting
      • Leukemia
      • +4 more
      • Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Nov 2, 2021

      AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))

      Terminated
      • AIDS-related Lymphoma
      • HIV Infections
      • PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
      • Hamburg, Germany
        University Medical Center Hamburg-Eppendorf
      Sep 4, 2022

      Peripheral Neuropathy, Trigeminal Neuralgia Trial in St. John's (AlloRx)

      Recruiting
      • Peripheral Neuropathy
      • Trigeminal Neuralgia
      • AlloRx
      • St. John's, Antigua and Barbuda
        Medical Surgical Associates Center
      Jan 4, 2022

      Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

      Terminated
      • Acute Biphenotypic Leukemia
      • +29 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 4, 2023

      Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

      Recruiting
      • Retinal Disease
      • +17 more
      • Arm 1
      • Westport, Connecticut
      • +2 more
      Nov 25, 2022

      Sickle Cell Disease Trial in Los Angeles (ßAS3-FB vector transduced peripheral blood CD34+ cells)

      Recruiting
      • Sickle Cell Disease
      • βAS3-FB vector transduced peripheral blood CD34+ cells
      • Los Angeles, California
        University of California, Los Angeles (UCLA)
      Apr 9, 2022

      Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

      Recruiting
      • Crohn's Disease
      • autologous CD34-selected peripheral blood stem cells transplant
      • +8 more
      • Pittsburgh, Pennsylvania
      • +1 more
      Feb 9, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow

      Available
      • Benign Neoplasm
      • +3 more
      • Bone Marrow Transplantation
      • +2 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Dec 9, 2021

      Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

      Completed
      • Chronic Myeloproliferative Disorders
      • +5 more
      • sargramostim
      • Buffalo, New York
        Roswell Park Cancer Institute
      Oct 3, 2022

      Leukemia, Bone Marrow Failure Syndrome, Immunodeficiencies Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using

      Available
      • Leukemia
      • +2 more
      • Apha/beta T and CD19+ cell depletion using CliniMACS device
      • Philadelphia, Pennsylvania
        Children's Hospital of Philadelphia
      Nov 2, 2021

      Metabolic Disease, Endothelial Dysfunction Trial (Peripheral Intravenous (IV) infusion of LMSCs)

      Not yet recruiting
      • Metabolic Disease
      • Endothelial Dysfunction
      • Peripheral Intravenous (IV) infusion of LMSCs
      • (no location specified)
      Mar 4, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023